PARP-deficient mice were shown to be protected from angiotensin II-induced cardiac hypertrophy, and it was suggested that PARP contributes to the angiotensin II-induced signaling pathways leading to cardiac hypertrophy and failure [36]. This evidence concerns the gene AGT and cardiac hypertrophy.